New Imatinib Derivatives with Antiproliferative Activity against A549 and K562 Cancer Cells
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27030750
Abstract: Tyrosine kinase enzymes are among the primary molecular targets for the treatment of some human neoplasms, such as those in lung cancer and chronic myeloid leukemia. Mutations in the enzyme domain can cause resistance and… read more here.
Keywords: cancer; a549 k562; difluorinated compound; k562 ... See more keywords